Vincent D et al. |
Dissociation between LPS-induced bronchial hyperreactivity and airway edema in the guinea-pig. |
1991 |
Agents Actions |
pmid:1793031
|
Desai S and Barton R |
Role of platelet activating factor in the pathogenesis of active and passive models of experimental allergic encephalomyelitis in the rat. |
1990 |
Agents Actions |
pmid:2285021
|
Howat DW et al. |
An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats. |
1989 |
Agents Actions |
pmid:2801340
|
Appleby P and Bowen JG |
Cutaneous inflammatory disorders. |
1990 |
Agents Actions |
pmid:2117335
|
Lundgren JD et al. |
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: involvement of the lipoxygenase pathway. |
1990 |
Agents Actions |
pmid:2117336
|
Doyle SA et al. |
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid. |
1990 |
Agents Actions |
pmid:2178317
|
Swingle KF and Reiter MJ |
Inhibition of Paf-acether-induced edema of the rat's paw. |
1986 |
Agents Actions |
pmid:2875631
|
Flower RJ |
Background and discovery of lipocortins. |
1986 |
Agents Actions |
pmid:2938452
|
Adnot S et al. |
Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. |
1987 |
Agents Actions |
pmid:3115070
|
Montrucchio G et al. |
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. |
1987 |
Agents Actions |
pmid:3115072
|
Morley J |
Platelet activating factor and asthma. |
1986 |
Agents Actions |
pmid:3099555
|
Cahill M et al. |
Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. |
1988 |
Agents Actions |
pmid:3051930
|
Cunha FQ et al. |
Failure of PAF-acether to induce in vivo neutrophil migration. |
1988 |
Agents Actions |
pmid:3055873
|
Touvay C et al. |
Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba. |
1986 |
Agents Actions |
pmid:3754380
|
Lauri D et al. |
Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin. |
1986 |
Agents Actions |
pmid:3706054
|
Etienne A et al. |
In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021. |
1986 |
Agents Actions |
pmid:3515870
|
Mastacchi R et al. |
Interaction of a new low molecular weight heparin (OP/LMWH) with human platelets. |
1986 |
Agents Actions |
pmid:3518359
|
Pettipher ER et al. |
PAF-acether in chronic arthritis. |
1987 |
Agents Actions |
pmid:3630862
|
Archer CB et al. |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether. |
1985 |
Agents Actions |
pmid:3923788
|
Parente L et al. |
The effect of glucocorticoids on lyso-PAF formation in vitro and in vivo. |
1986 |
Agents Actions |
pmid:3962774
|
Tarayre JP et al. |
Inflammatory action of PAF-acether in the rat pleural cavity. |
1986 |
Agents Actions |
pmid:3962789
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Spicer BA et al. |
An investigation of the involvement of platelet activating factor in the non-histamine immediate hypersensitivity reaction in the rat peritoneal cavity. |
1985 |
Agents Actions |
pmid:4003197
|
Boughton-Smith NK et al. |
Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat. |
1992 |
Agents Actions |
pmid:1279960
|
Okamoto H et al. |
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. |
1992 |
Agents Actions |
pmid:1388318
|
Rachmilewitz D et al. |
Cytokines and platelet-activating factor in human inflamed colonic mucosa. |
1992 |
Agents Actions |
pmid:1359744
|
Ogunbiyi PO and Eyre P |
Pharmacological studies of pulmonary anaphylaxis in vitro: a review. |
1985 |
Agents Actions |
pmid:2420161
|
Canale P et al. |
TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock. |
1994 |
Agents Actions |
pmid:7879698
|
Kantar A et al. |
Effect of PAF on human lymphocyte membranes: a fluorescence study. |
1993 |
Agents Actions |
pmid:8317302
|
Boonen GJ et al. |
Activation of neutrophil migration by dioctanoyl-sn-glycerol and fMet-Leu-Phe is controlled by different pathways. |
1993 |
Agents Actions |
pmid:8317308
|
Murphy G |
Report of the 14th meeting of the British Inflammation Research Association. Topic: cellular and molecular aspects of inflammatory bowel disease. |
1993 |
Agents Actions |
pmid:8480529
|
Sakamoto T et al. |
Effect of beta 2-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig. |
1993 |
Agents Actions |
pmid:7908496
|
Denburg JA et al. |
Platelet activating factor: regulation by mast cells and aspirin. |
1984 |
Agents Actions |
pmid:6711391
|
Mencia-Huerta JM et al. |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process? |
1981 |
Agents Actions |
pmid:7053072
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of PAF-acether. Preliminary results after the intravenous administration of a 3H-labelled product to the rabbit. |
1982 |
Agents Actions |
pmid:7164941
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|
Borrel MC et al. |
Additional techniques for the total synthesis of PAF-acether. |
1982 |
Agents Actions |
pmid:7164944
|
Benveniste J et al. |
Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types. |
1982 |
Agents Actions |
pmid:7164945
|
Arnoux B et al. |
Release of PAF-acether from human blood monocytes. |
1982 |
Agents Actions |
pmid:7164946
|
Fouque F et al. |
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action. |
1982 |
Agents Actions |
pmid:7164947
|
Lefort J et al. |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions. |
1982 |
Agents Actions |
pmid:7164948
|
Bonnet J et al. |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. |
1981 |
Agents Actions |
pmid:7340441
|
Denjean A et al. |
Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons. |
1981 |
Agents Actions |
pmid:7340444
|
Louis R et al. |
Potentiation of histamine release from human leucocytes by PAF. |
1994 |
Agents Actions |
pmid:7521570
|
Izzo AA et al. |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents. |
1994 |
Agents Actions |
pmid:7524288
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Kelefiotis D and Vakirtzi-Lemonias C |
In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis. |
1993 |
Agents Actions |
pmid:8023738
|
Northover AM and Northover BJ |
Involvement of protein kinase C in the control of microvascular permeability to colloidal carbon. |
1993 |
Agents Actions |
pmid:8304240
|